Pharmacotherapeutic approaches for treating psoriasis in difficult-to-treat areas
- 22 March 2018
- journal article
- review article
- Published by Taylor & Francis Ltd in Expert Opinion on Pharmacotherapy
- Vol. 19 (6), 561-575
- https://doi.org/10.1080/14656566.2018.1448788
Abstract
Introduction: Despite great therapeutic advancements in psoriasis, four notable difficult-to-treat areas including the scalp, nails, intertriginous (including genitals), and palmoplantar regions, pose a challenge to both physicians and patients. Localized disease of these specific body regions inflicts a significant burden on patients’ quality of life and requires an adequate selection of treatments. Areas covered: This manuscript discusses appropriate therapies and important treatment considerations for these difficult-to-treat areas based on the available clinical data from the literature. Expert opinion: Clinical trials assessing therapies for the difficult-to-treat areas have been inadequate. With the first biological clinical trial for genital psoriasis pending publication, it is with hope that other biological agents will be evaluated for region-specific psoriasis. A greater understanding of the genetic and immunologic aspects of regional psoriasis, as well as identification of unique biomarkers, will further guide management decisions. For example, the recent discovery of the IL-36 receptor gene for generalized pustular psoriasis may prove valuable for other forms of psoriasis. Ultimately, identification of the most beneficial treatments for each psoriasis subtype and difficult-to-treat area will provide patients with maximal quality of life.Keywords
Funding Information
- Nil (0)
This publication has 100 references indexed in Scilit:
- Nail Psoriasis: Treatment With Tazarotene 0.1% Hydrophilic OintmentActas Dermo-Sifiliográficas (English Edition), 2012
- Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: Case-based presentations and evidence-based conclusionsJournal of the American Academy of Dermatology, 2011
- Evaluation of topical 0.1% tazarotene cream in the treatment of palmoplantar psoriasis: An observer-blinded randomized controlled studyIndian Journal of Dermatology, 2011
- Tacalcitol ointment for the treatment of nail psoriasisJournal of Dermatological Treatment, 2009
- A randomized, open-label trial of continuous versus interrupted etanercept therapy in the treatment of psoriasisJournal of the American Academy of Dermatology, 2007
- The psoriasis variant palmoplantar pustulosis can be improved after cessation of smokingJournal of the American Academy of Dermatology, 2006
- Consistency of data in six phase III clinical studies of a two-compound product containing calcipotriol and betamethasone dipropionate ointment for the treatment of psoriasisJournal of the European Academy of Dermatology and Venereology, 2006
- Broad‐band UVB fiber‐optic comb for the treatment of scalp psoriasis: a pilot studyInternational Journal of Dermatology, 2004
- A double-blind, vehicle-controlled study of clobetasol propionate 0.05% (Temovate) scalp application in the treatment of moderate to severe scalp psoriasisJournal of the American Academy of Dermatology, 1991
- Corticosteroid-induced ‘disappearing digit’Journal of the American Academy of Dermatology, 1990